Triamcinolone Acetonide Dosing for Acne and Keloids
Acne Nodules
For inflammatory nodular acne, inject triamcinolone acetonide at 10 mg/mL (which may be diluted to 5 or 3.3 mg/mL with sterile normal saline), using 0.05-0.1 mL per injection site. 1
- This concentration provides rapid symptom relief within 48-72 hours for individual stubborn cystic lesions 1
- The injection should be placed just beneath the dermis in the upper subcutis 2
- Each 0.05-0.1 mL injection produces a response area approximately 0.5 cm in diameter 1
- Intralesional corticosteroid injections are effective for treating individual acne nodules, particularly in patients at risk of scarring who require rapid improvement in inflammation and pain 2, 1
Important Limitations for Acne Treatment
- This approach is not effective as primary treatment for multiple lesions—use it judiciously for occasional stubborn cystic lesions only 1
- Treating multiple acne lesions with intralesional steroids is not an effective strategy 1
Keloids and Hypertrophic Scars
For keloids, the standard concentration is triamcinolone acetonide 40 mg/mL injected intralesionally, though lower concentrations of 5-10 mg/mL may be used depending on lesion characteristics and to reduce atrophy risk. 1
Dosing Protocol
- Inject just beneath the dermis in the upper subcutis 1
- Administer at monthly intervals 3
- Treatment duration typically extends 6-8 months 4, 3
- The response to corticosteroid injection alone is variable with 50-100% regression 5
Recurrence and Efficacy Concerns
- Monotherapy with triamcinolone alone yields poor long-term results with recurrence rates of 33% at 1 year and 50% at 5 years 5
- Triamcinolone alone showed only 15-20% good to excellent improvement rates in comparative studies 4
Combination Therapy for Keloids (Preferred Approach)
The combination of triamcinolone acetonide 40 mg/mL with 5-fluorouracil 50 mg/mL in a 1:1 ratio is more effective than either agent alone and produces fewer side effects. 1, 4, 3
Specific Combination Protocol
- Mix 0.1 mL of triamcinolone acetonide 40 mg/mL with 0.9 mL of 5-fluorouracil 50 mg/mL 4
- Inject weekly for 8 weeks, then reassess 4
- This combination achieved 40-55% good to excellent improvement compared to 15-20% with triamcinolone alone 4
- A more recent study showed 95% good to excellent response with the combination versus 70% with triamcinolone alone 3
Why Combination Therapy is Superior
- Combination therapy shows better outcomes with fewer side effects than either agent alone 1
- The combination produces faster response and more stable long-term results 5, 3
- Adding pulsed-dye laser to the triamcinolone/5-FU combination further improves outcomes to 70-75% good to excellent response 4
Adverse Effects and Risk Mitigation
Local Complications
- Skin atrophy occurs in 44% of patients treated with triamcinolone alone but only 8% with 5-FU alone 6
- Telangiectasias develop in 50% with triamcinolone versus 21% with 5-FU 6
- Pigmentary changes (both hypopigmentation and hyperpigmentation) can occur 1
- Atrophy and telangiectasia were seen in 37% of patients receiving triamcinolone alone for keloids 4
Strategies to Minimize Adverse Effects
- Use lower concentrations and volumes to reduce atrophy risk 1
- Decreasing concentration from 40 mg/mL to 10 mg/mL or diluting to 5 mg/mL significantly reduces atrophy risk 1
- Avoid injecting too superficially, as this dramatically increases the risk of atrophy and pigmentary changes 1
- Do not use excessive concentration or volume 1
Systemic Complications
- Hypothalamic-pituitary-adrenal axis suppression can occur with repeated injections 1
- Rare cases of anaphylaxis, angioedema, and urticaria have been reported 1
- Consider impaired wound healing and increased infection risk at injection sites 1
Clinical Pitfalls to Avoid
- Never inject too superficially—this increases atrophy and pigmentary change risk 1
- Avoid using triamcinolone monotherapy for keloids—combination therapy is superior 1, 5
- Do not attempt to treat multiple acne lesions with intralesional steroids—this is ineffective 1
- Do not use excessive volumes—stick to 0.05-0.1 mL per injection site 1